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CASE PRESENTATION
A previously healthy 46-year-old African-American man
presented to an outside hospital with several weeks of
fever, 20 lb weight loss in the previous month, and left
flank pain. He was hypertensive, urinalysis was notable for
the absence of protein, blood, and cellular elements, and
the erythrocyte sedimentation rate was minimally
elevated at 23 mm/h. His family history was relevant for
uncomplicated hypertension in both parents. CT scan with
intravenous contrast demonstrated bilateral renal
infarctions, and serum creatinine rose from 1.2 to
1.7 mg/dl shortly after admission. Renal angiography
revealed stenoses in both main renal arteries, as well as
in first- and second-order branches of the vasculature
to the right upper pole. Aneurysmal dilatations were
present in the upper pole branches and at the left hilum.
Given the radiographical findings and systemic
complaints, the patient was diagnosed with polyarteritis
nodosa (PAN) and initiated on steroid therapy. One week
after discharge, the patient complained of chest pain in
the setting of persistent flank pain, and his serum
creatinine had risen to 2.3 mg/dl. He was readmitted to
the hospital, myocardial infarction was excluded, and
he was transferred to the Johns Hopkins Hospital for
further evaluation.
On transfer, the patient was taking prednisone
80 mg/day, lisinopril 20 mg/day, amlodipine, and atenolol.
On physical examination, he was afebrile, blood pressure
135/77 mm Hg, pulse 64/min, and respirations 20/min.
Physical findings were significant for normal pulmonary
and cardiovascular examinations and the presence
of costovertebral angle tenderness bilaterally.
Laboratory studies on admission (Table 1) were
notable for mild-to-moderate renal dysfunction with
mild anemia and normal markers of inflammation.
Urinalysis was unrevealing, and proteinuria was estimated
at 0.22 gProtein/gCreatinine on a spot urine sample.
In an attempt to confirm the diagnosis of PAN, the
patient underwent testicular ultrasound and mesenteric
angiography, both of which were normal. Selective renal
angiography was then performed with intravascular
ultrasound (IVUS). Angiography demonstrated a tight left
mid-renal artery narrowing (Figure 1) with focal areas of
infarction throughout the renal parenchyma (Figure 2).
This stenosis had mildly worsened since the initial
studies, and IVUS demonstrated the presence of a focal
dissection flap (Figure 3). In addition, moderate
improvement since the prior study was seen in both
the stenosis of the right upper pole arterial branch
and the associated aneurysm.
CLINICAL DIAGNOSIS
Bilateral intimal fibromuscular dysplasia (FMD) of the renal
arteries, complicated by dissection.
CLINICAL FOLLOW-UP
The renal artery findings were compatible with FMD, and
intervention was postponed due to the large volume of
iodinated contrast the patient had received in the preceding
days. The initial rise in serum creatinine at the outside
hospital was in the setting of renal infarction and adminis-
tration of intravenous contrast for CT imaging. He under-
went angioplasty of the left renal artery 3 months later with
improvement in the mean pressure gradient across the
stenosis from 12 to 2 mm Hg. Intervention to the right renal
artery was deferred, as the upper pole stenosis had
spontaneously improved. At discharge, the creatinine was
1.2 mg/dl, and his blood pressure was 122/78 mm Hg off of
antihypertensive therapy.
DISCUSSION
Here we present a case of bilateral intimal FMD with
unilateral dissection and infarction in a 46-year-old African-
American man initially diagnosed with PAN.
Fibromuscular dysplasia
Fibromuscular dysplasia is a non-atherosclerotic, non-inflam-
matory vascular disease of largely unknown pathogenesis
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that primarily affects the renal and cerebral arteries, although
any arterial bed can be involved.1 Patients with FMD
can remain asymptomatic or present with hypertension,
stroke, abdominal angina, claudication, or other signs
of vascular insufficiency. Proposed etiologic mechanisms
include hormonal factors, mechanical trauma, metabolic
and immunologic factors, intrinsic deficiency of elastic fibers,
and genetic predisposition.2 In one study, 11 of 100 patients
had familial renal artery FMD, defined as angiographic
evidence of renal artery FMD in at least one sibling.3 These
familial cases tended to be bilateral with multifocal lesions. In
addition, subclinical arterial disease has been demonstrated
in relatives of FMD patients by carotid artery echotracking.4
Although the parents of this patient had hypertension, they
did not have a clinical history of underlying FMD.
The classification scheme for FMD is based on the arterial
layer involved: intimal, medial, or periadventitial.5 Medial
FMD is further subdivided into medial fibroplasia, perime-
dial fibroplasia, and medial hyperplasia. Medial fibroplasia
accounts for 70–95% of all cases of FMD and has the classical
‘string of beads’ appearance on angiography due to alternat-
ing areas of stenosis and aneurysmal dilatation. Intimal FMD,
occurring in only 1–5% of patients, is far less common and
has multiple angiographic presentations. Concentric band-
like stenoses and smooth tapered lesions similar to those
seen in large-vessel vasculitis have been described.1 Collagen
deposition results in a thickened intima, often with
fragmentation or duplication of the internal elastic lamina.
Duplication appears to be more common in children and
adolescents. Concentric stenosis with post-stenotic dilatation
is associated with preservation of the elastic lamina on
histological examination, whereas irregular, dilated arterial
segments are more common with disruption of the elastic
lamina.6 Medial hyperplasia also presents with a uniform,
smooth stenosis and can be difficult to differentiate
angiographically from intimal fibroplasia. The combination
of a tapering lesion with a superimposed focal concentric
narrowing, as shown in Figure 1, is most consistent with
intimal fibroplasia in this patient. Primary intimal fibroplasia
must be differentiated from secondary causes, such as prior
episodes of malignant hypertension, chronic pyelonephritis,
or end-stage renal disease. Primary intimal fibroplasia,
however, involves renal arterial branches larger than an
interlobar artery, as opposed to the involvement of smaller
Table 1 | Serum, hematological, and urine studies at transfer
Sodium 134 mEq/l White blood cell 16,470/mm3
Potassium 4.9 mEq/l Hemoglobin 12.6 g/dl
Chloride 96 mEq/l Platelets 200,000/mm3
Total CO2 26 mEq/l ESR 5 mm/h
Blood urea
nitrogen
38 mg/dl C-reactive
protein
o0.3 mg/dl
Creatinine 1.7 mg/dl Urinalysis Negative dipstick
Glucose 123 mg/dl Urine microscopic
exam
Acellular
Calcium 9.2 mg/dl Urine protein/
creatinine
0.22 gProt/gCr
Albumin 4.0 mg/dl
ESR, erythrocyte sedimentation rate.
Figure 1 | Selective digital subtraction angiography shows
focal area of narrowing in the mid left renal artery (arrow).
Figure 2 | Parenchymal phase of the angiogram reveals area
of infarction involving the left upper pole (arrow).
TL
Figure 3 | Intravascular ultrasound of the left renal artery
narrowing demonstrates a focal, thrombosed dissection flap
(arrow). TL, true arterial lumen.
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vasculature seen in secondary processes.7 As such, percuta-
neous renal biopsy will typically not make a diagnosis of
FMD, and most cases of FMD do not involve histological
evaluation of tissue specimens.
Renovascular FMD, accounting for 65% of FMD, is
usually seen in Caucasian women between 15 and 50 years of
age, although cases have been reported in asymptomatic
patients older than 60 years. Renovascular hypertension may
be less common in African-Americans, especially in men.8
Although women comprise 82% of the cases of medial FMD,
only 36% of intimal FMD cases are found in women.9 Intimal
FMD is more common in young persons, presenting as
unifocal or multifocal stenoses that progress to renal artery
dissection. When intimal fibroplasia involves multiple
branches of the renal arteries as in this patient, dissection
and renal ischemia may be more common than with other
subtypes of FMD.3,10,11
Diagnostic dilemma
The differential diagnosis of renovascular FMD includes
atherosclerosis, vasculitis, and vascular lesions of neuro-
fibromatosis (Table 2). There have also been reports of
medial fibroplasia associated with disorders of connective
tissue, such as Ehlers–Danlos syndrome, Marfan’s syndrome,
and Alport’s syndrome.12–14 Atherosclerotic disease typically
occurs at the ostia or proximal portions of arteries in older
patients who have additional cardiovascular risk factors.
Conversely, FMD usually occurs in the distal two-thirds of
the renal arteries.
As in this case, FMD has frequently been misdiagnosed as
vasculitis, and in particular, PAN and giant cell arteritis.15,16
Although PAN and FMD have distinct histopathological
characteristics, both are usually diagnosed angiographically.
Other techniques to diagnose FMD include duplex ultra-
sonography, CT angiography, and magnetic resonance
angiography. CT angiography has variable efficacy in the
diagnosis of FMD, with a combination of maximum-
intensity projection reconstructions and transverse sections
yielding more definitive diagnosis.17 Contrast-enhanced
magnetic resonance angiography correlates well with digital
subtraction angiography, with a sensitivity of 97% and
specificity of 93%. Magnetic resonance angiography better
detects the ‘string of pearls’ than it does other stenotic
lesions.18 Renal angiography remains the gold standard for
the diagnosis of FMD and PAN. Multiple focal visceral/renal
aneurysms (up to 1 cm in size) are considered virtually
pathognomonic for PAN, with a specificity of 95%.16
Nonetheless, multivessel intimal fibroplasia can have an
appearance similar to vasculitis. Moreover, the clinical
features of PAN are due to organ infarction and hemorrhage
secondary to necrotizing vasculitis of medium-sized mus-
cular arteries. Common signs and symptoms include
constitutional complaints, hypertension, renal impairment,
peripheral neuropathy, abdominal pain, musculoskeletal
involvement, skin lesions, and cerebrovascular accidents.
PAN is often lethal without prompt treatment, and incorrect
diagnosis may lead to improper use of steroids and cytotoxic
agents. FMD, however, is a non-inflammatory disease. It is,
therefore, not associated with typical laboratory abnormal-
ities of vasculitis, such as anemia, increased erythrocyte
sedimentation rate, and elevated level of C-reactive protein.
Intravascular ultrasound
Given the similarity of FMD and vasculitis by angiography,
additional diagnostic modalities may be useful. This patient
underwent renal angiography with IVUS to confirm the
diagnosis of FMD. With IVUS, a dissection flap in the
left renal artery was diagnosed that was not discerned by
traditional angiography. Although it is not possible to
distinguish a spontaneous dissection due to FMD from one
caused by the previous catheterization, the presence of an
arterial dissection would be consistent with the natural
history of this disease. IVUS has been utilized to gauge
restenosis of renal artery stents and can detect anatomical
abnormalities of the arterial wall that are not visualized by
traditional angiography.19,20 Classic IVUS findings in FMD
include a beaded appearance produced by multiple, eccentric,
cleft-like stenoses. In a small study by Sheikh et al.,21
angiography and catheter-based IVUS correlated closely in
the determination of arterial lumen diameter (r¼ 0.81) and
cross-sectional area (r¼ 0.83). Additionally, IVUS provided
structural information not shown by angiography: out of five
stenotic segments, angiography identified atherosclerosis in
four and FMD in one, whereas IVUS identified athero-
sclerosis in three and FMD in two. IVUS also showed three
arterial dissections, whereas angiography identified only one.
Gowda et al.20 studied 20 women with drug-resistant
hypertension in whom color-flow duplex imaging suggested
renal artery FMD. Patients underwent renal angiography,
revealing classic FMD in only eight, borderline abnormalities
in seven, and normal angiograms in five. Conversely, in all
patients, IVUS demonstrated endoluminal abnormalities
localized to the irregular segments detected by color-flow
duplex imaging. After balloon angioplasty, IVUS findings
were completely eliminated in 16 patients and improved in 4.
The ability of IVUS to detect vascular abnormalities in
suspected FMD when angiography is unrevealing supports
the increased use of this modality at centers where it is
available. It may prove useful in discriminating indeterminate
lesions in patients also at risk for atherosclerotic renal artery
stenosis. The low-intensity echoes of fibromuscular lesions
Table 2 | Conditions associated with or mimicking FMD
Atherosclerotic renal artery stenosis
Vasculitis
Polyarteritis nodosa
Giant cell arteritis
Renal artery dissection
Vascular lesions of neurofibromatosis
Ehlers–Danlos syndrome
Marfan’s syndrome
Alport’s syndrome
a1-Antitrypsin deficiency
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can be readily distinguished from the echogenic appearance
of calcified plaque.22 A randomized trial, however, will be
necessary to fully evaluate whether IVUS leads to improved
outcomes over standard imaging approaches.
Treatment of FMD
Currently, the mainstay of intervention is percutaneous
transluminal balloon angioplasty for patients with difficult-
to-control hypertension, renal insufficiency, or arterial
dissection. Success rates range from 87 to 100%, with many
patients experiencing a prompt reduction in blood pres-
sure.23,24 Hypertension of long-standing duration portends a
lesser antihypertensive effect of revascularization, likely
representing irreversible systemic vascular remodeling or the
co-existence of essential hypertension. Unlike with athero-
sclerotic renovascular disease, intraluminal stents are typically
not required. Recurrent disease following angioplasty or the
presence of a dissection may prompt the use of vascular
stents. The ability of IVUS to detect dissections not seen by
angiography may impact the initial decision to stent a lesion
of FMD, but few data exist to guide this decision. Angio-
graphically documented recurrence rates of 6.7–12% following
balloon angioplasty have been reported at 6–12 months, and
intimal FMD is not necessarily more likely to reoccur than
other subtypes.24–26 The ideal method of monitoring for
disease recurrence has not been rigorously determined, but
screening duplex ultrasonography is typically utilized at 1,
6, and 12 months post-procedure and annually thereafter.
Surgical revascularization—once a mainstay of therapy—is
rarely indicated in modern management of FMD.
Complications of FMD
Fibromuscular dysplasia rarely progresses to complete
stenosis. Complications of FMD include dissection, aneu-
rysm formation, and arteriovenous fistulas. In a predomi-
nately male case series of 24 patients from the Mayo Clinic,
22 patients experiencing isolated, non-traumatic renal
artery dissection were found to have FMD.27 Spontaneous
dissection of the renal artery is an acute and dangerous
complication that can lead to infarction and impaired renal
function. Corticosteroid therapy, whether appropriate or
inappropriate, may lead to or worsen pre-existing hyper-
tension. The pleiotropic effects of corticosteroids contribute
to vascular wall remodeling, which may lead to weakening of
arterial walls and aneurysm rupture.
SUMMARY
Fibromuscular dysplasia is characteristically seen in young
Caucasian females, but it must be considered a cause of renal
artery stenosis and resistant hypertension in all patients.
Intimal FMD accounts for less than 10% of cases. Although
angiography is the gold standard for diagnosis of FMD, the
radiographical findings can at times be confused with those
seen in atherosclerotic vascular disease and vasculitides such
as PAN. IVUS may reveal findings consistent with FMD not
otherwise seen by angiography. The role of IVUS in the
routine evaluation of suspected FMD, and the most
efficient strategy of monitoring for disease recurrence post-
angioplasty, remain to be determined.
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